Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts

$76.23

+1.10 (+1.46%)

(As of 09:34 AM ET)

GILD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GILD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad DTI

3 dividend stocks to own

The “Income Ace” Jack Carter just revealed his entire dividend strategy. Including 3 specific tickers to consider owning. And his “golden rules” for trading dividend stocks. These aren’t just theoretical rules, either. Jack revealed that the vast majority of his income capital is deployed in this straightforward portfolio of dividend stocks.

Watch this presentation asap.

Gilead Sciences Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	4	($1.42)	$1.97	$0.94
Q2 2024	4	$1.51	$1.98	$1.75
Q3 2024	4	$1.75	$2.10	$1.91
Q4 2024	4	$1.79	$1.86	$1.84
FY 2024	16	$3.63	$7.91	$6.43
Q1 2025	1	$1.59	$1.59	$1.59
Q2 2025	1	$1.67	$1.67	$1.67
Q3 2025	1	$2.06	$2.06	$2.06
Q4 2025	1	$1.86	$1.86	$1.86
FY 2025	4	$7.18	$7.18	$7.18
Q1 2026	1	$1.56	$1.56	$1.56

GILD Earnings Date and Information

Gilead Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.

Gilead Sciences Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/5/2024 (Estimated)	-	-	-	-	-	-	-
4/25/2024	Q1 2024	($1.49)	($1.32)	+$0.17	$0.70	$6.36 billion	$6.69 billion
2/6/2024	Q4 2023	$1.76	$1.72	($0.04)	$2.30	$7.10 billion	$7.12 billion
11/7/2023	Q3 2023	$1.91	$2.29	+$0.38	$2.85	$6.81 billion	$7.05 billion
8/3/2023	Q2 2023	$1.64	$1.34	($0.30)	$1.85	$6.45 billion	$6.60 billion
4/27/2023	Q1 2023	$1.63	$1.37	($0.26)	$1.94	$6.33 billion	$6.35 billion
2/2/2023	Q4 2022	$1.50	$1.67	+$0.17	$2.04	$6.63 billion	$7.39 billion
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter.
10/27/2022	Q3 2022	$1.44	$1.90	+$0.46	$2.38	$6.12 billion	$7.04 billion
8/2/2022	Q2 2022	$1.51	$1.58	+$0.07	$2.25	$5.88 billion	$6.26 billion
4/28/2022	Q1 2022	$1.77	$2.12	+$0.35	$4.22	$6.28 billion	$6.59 billion
2/1/2022	Q4 2021	$1.53	$0.69	($0.84)	$1.08	$6.64 billion	$7.24 billion
10/28/2021	Q3 2021	$1.72	$2.65	+$0.93	$3.25	$6.31 billion	$7.42 billion
7/29/2021	Q2 2021	$1.76	$1.87	+$0.11	$2.53	$6.15 billion	$6.22 billion
4/29/2021	Q1 2021	$2.06	$2.08	+$0.02	$2.79	$6.78 billion	$6.42 billion
2/4/2021	Q4 2020	$2.15	$2.19	+$0.04	$3.15	$7.11 billion	$7.42 billion
10/28/2020	Q3 2020	$1.90	$2.11	+$0.21	$3.93	$6.20 billion	$6.58 billion
7/30/2020	Q2 2020	$1.57	$1.11	($0.46)	$4.88	$5.24 billion	$5.14 billion
4/30/2020	Q1 2020	$1.57	$1.68	+$0.11	$2.14	$5.44 billion	$5.55 billion
2/4/2020	Q4 2019	$1.67	$1.30	($0.37)	$0.08	$5.74 billion	$5.88 billion
10/24/2019	Q3 2019	$1.74	$1.75	+$0.01	$4.22	$5.61 billion	$5.60 billion

Gilead Sciences Earnings - Frequently Asked Questions

When is Gilead Sciences's earnings date?: Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on GILD's earnings history.
What guidance has Gilead Sciences issued on next quarter's earnings?: Gilead Sciences issued an update on its FY 2024 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of 3.600-3.900 for the period, compared to the consensus estimate of 3.750. The company issued revenue guidance of $27.1 billion-$27.5 billion, compared to the consensus revenue estimate of $27.6 billion.
How much revenue does Gilead Sciences generate each year?: Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.81 billion.
How much profit does Gilead Sciences generate each year?: Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $0.36 earnings per share over the last four quarters.
What is Gilead Sciences's price-to-earnings ratio?: Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 208.69 and a forward price-to-earnings ratio of 20.14. The price/earnings-to-growth ratio is 3.37.
What is Gilead Sciences's EPS forecast for next year?: Gilead Sciences's earnings are expected to grow from $3.73 per share to $7.21 per share in the next year, which is a 93.30% increase.